Grassley And Baucus Turn Up Heat On GSK With Attack On Avandia Data Handling
This article was originally published in The Pink Sheet Daily
Executive Summary
Company's internal e-mails suggest GSK hid vital studies related to safety of Avandia relative to competitor, senators charge.